배란 검사 키트 시장 기회, 성장요인, 업계 동향 분석 및 예측(2026-2035년)

The Global Ovulation Testing Kits Market was valued at USD 496.2 million in 2025 and is estimated to grow at a CAGR of 7.2% to reach USD 1 billion by 2035.

The market is witnessing steady growth due to rising incidences of polycystic ovary syndrome (PCOS), hormonal irregularities, and increasing awareness surrounding assisted reproductive techniques such as IVF. Growing emphasis on fertility awareness and proactive reproductive health management is further accelerating adoption across global populations. Continuous advancements in diagnostic technologies are improving the accuracy, ease of use, and accessibility of ovulation testing solutions, encouraging wider consumer acceptance. These kits enable individuals to identify fertile windows by detecting hormonal changes, particularly luteinizing hormone surges, thereby supporting better family planning decisions. Increasing awareness of menstrual health conditions and the rising trend of self-monitoring health solutions are also contributing to market expansion. In addition, improved distribution networks, rising healthcare awareness campaigns, and growing availability through both physical and online channels are supporting product penetration. Expanding female workforce participation and delayed pregnancy trends in several regions are further boosting demand for convenient at-home fertility tracking solutions, strengthening the long-term growth outlook of the market globally.

The urine-based ovulation testing kits segment generated USD 271.5 million in 2025. This dominance is attributed to its affordability, high reliability, and ease of accessibility for consumers. These kits are widely available in various formats such as strips, cassettes, and midstream devices, making them convenient for regular use. Their ability to accurately detect luteinizing hormone surges has made them a preferred choice among users seeking dependable fertility tracking solutions.

The brick-and-mortar distribution channel is projected to reach USD 567.1 million by 2035, reflecting strong growth over the forecast period. Physical retail outlets remain a key sales channel due to consumer preference for immediate availability and a direct purchase experience. Pharmacies, supermarkets, and specialty health stores continue to play an important role in product distribution, often supported by professional guidance from healthcare staff. This channel also strengthens consumer confidence through direct product evaluation and brand comparison, particularly in regions where digital adoption is relatively limited.

United States Ovulation Testing Kits Market was valued at USD 179.2 million in 2025, and is expected to grow at a CAGR of 7% from 2026 to 2035. Market growth in the country is primarily driven by the increasing prevalence of PCOS and hormonal disorders that disrupt normal ovulation cycles. Rising awareness and improved diagnosis rates, supported by advanced healthcare infrastructure, are encouraging more women to adopt fertility tracking solutions. Growing focus on reproductive health management and early detection of hormonal imbalances is further supporting market expansion across the region.

Major players operating in the Global Ovulation Testing Kits Industry include Church & Dwight Co., Inc., QuidelOrtho Corporation, SPD Swiss Precision Diagnostics GmbH, Geratherm Medical AG, Fairhaven Health, LLC, Clinical Guard LLC, Premom Inc., Ubio Biotechnology Systems, Hangzhou AllTest Biotech Co., Ltd., Mankind Pharma Ltd., and Nantong Diagnos Biotechnology Co., Ltd. Companies in the ovulation testing kits market are focusing on strengthening their market presence through continuous product innovation, particularly by improving test accuracy, digital integration, and user-friendly formats. They are expanding distribution networks across both online and offline channels to improve product accessibility. Strategic investments in digital fertility tracking platforms and mobile applications are enhancing consumer engagement and retention. Manufacturers are also emphasizing affordability while maintaining diagnostic reliability to reach wider consumer bases. Partnerships with healthcare providers and pharmacies are helping improve trust and product visibility. In addition, companies are increasing awareness campaigns focused on reproductive health and fertility education. Expansion into emerging markets with growing healthcare awareness is further supporting long-term growth and competitive positioning in the global market.

Table of Contents

Chapter 1 Research Methodology

• 1.1 Research approach
• 1.2 Quality commitments
  • 1.2.1 GMI AI policy & data integrity commitment
    • 1.2.1.1 Source consistency protocol
• 1.3 Research trail & confidence scoring
  • 1.3.1 Research trail components
  • 1.3.2 Scoring components
• 1.4 Data collection
  • 1.4.1 Partial list of primary sources
• 1.5 Data mining sources
  • 1.5.1 Paid sources
    • 1.5.1.1 Sources, by region
• 1.6 Base estimates and calculations
  • 1.6.1 Base year calculation for any one approach
• 1.7 Forecast model
  • 1.7.1 Quantified market impact analysis
    • 1.7.1.1 Mathematical impact of growth parameters on forecast
• 1.8 Research transparency addendum
  • 1.8.1 Source attribution framework
  • 1.8.2 Quality assurance metrics
  • 1.8.3 Our commitment to trust

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis
• 2.2 Key market trends
  • 2.2.1 Product trends
  • 2.2.2 Sales Channel trends
  • 2.2.3 End use trends
  • 2.2.4 Regional trends
• 2.3 CXO perspectives: Strategic imperatives

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing prevalence of polycystic ovary syndrome (PCOS) and other hormonal disorders
    • 3.2.1.2 Rising awareness regarding IVF procedures
    • 3.2.1.3 Growing technological advancements in ovulation testing kits
    • 3.2.1.4 Rising number of fertility issues among women
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 Errors associated with ovulation test kits
    • 3.2.2.2 Stringent regulatory scenario
  • 3.2.3 Market opportunities
    • 3.2.3.1 Integration with fertility tracking apps & telemedicine platforms
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape (Driven by primary research)
  • 3.4.1 North America
  • 3.4.2 Europe
  • 3.4.3 Asia Pacific
  • 3.4.4 Latin America
  • 3.4.5 Middle East and Africa
• 3.5 Technology landscape (Driven by primary research)
  • 3.5.1 Current technological trends
    • 3.5.1.1 Multi-hormone detection systems
    • 3.5.1.2 High-sensitivity rapid test strips
  • 3.5.2 Emerging technologies
    • 3.5.2.1 Connected smart fertility ecosystems
    • 3.5.2.2 Non-invasive saliva-based and wearable solutions
• 3.6 Future market trends (Driven by primary research)
• 3.7 Impact of AI and Generative AI on the market (Driven by primary research)
• 3.8 Pricing trend analysis (Driven by primary research)
• 3.9 Porter’s analysis
• 3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2025

• 4.1 Introduction
• 4.2 Company market share analysis
  • 4.2.1 Global
  • 4.2.2 North America
  • 4.2.3 Europe
  • 4.2.4 Asia Pacific
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Key developments
  • 4.6.1 Mergers and acquisitions
  • 4.6.2 Partnerships and collaborations
  • 4.6.3 New product launches
  • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product, 2022 - 2035 ($ Mn)

• 5.1 Key trends
• 5.2 Urine-based ovulation testing kits
  • 5.2.1 Test strip type
  • 5.2.2 Cassette type
  • 5.2.3 Midstream type
• 5.3 Saliva-based ovulation testing kits
• 5.4 Digital ovulation testing kits

Chapter 6 Market Estimates and Forecast, By Sales Channel, 2022 - 2035 ($ Mn)

• 6.1 Key trends
• 6.2 Brick and mortar
• 6.3 E-commerce

Chapter 7 Market Estimates and Forecast, By End Use, 2022 - 2035 ($ Mn)

• 7.1 Key trends
• 7.2 Hospitals and fertility clinics
• 7.3 Home care
• 7.4 Other end users

Chapter 8 Market Estimates and Forecast, By Region, 2022 - 2035 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE

Chapter 9 Company Profiles

• 9.1 Church & Dwight Co., Inc.
• 9.2 Clinical Guard LLC
• 9.3 Cyclotest LH Test Strips
• 9.4 Fairhaven Health, LLC
• 9.5 Geratherm Medical AG
• 9.6 Ubio Biotechnology systems
• 9.7 Hangzhou AllTest Biotech Co., Ltd.
• 9.8 Mankind Pharma Ltd.
• 9.9 Nantong Diagnos Biotechnology Co., Ltd.
• 9.10 Premom Inc.
• 9.11 PRIMA Lab SA
• 9.12 QuidelOrtho Corporation
• 9.13 SPD Swiss Precision Diagnostics GmbH